BG101703A - Antiparasitic medicamentous form and method for itsapplication - Google Patents

Antiparasitic medicamentous form and method for itsapplication

Info

Publication number
BG101703A
BG101703A BG101703A BG10170397A BG101703A BG 101703 A BG101703 A BG 101703A BG 101703 A BG101703 A BG 101703A BG 10170397 A BG10170397 A BG 10170397A BG 101703 A BG101703 A BG 101703A
Authority
BG
Bulgaria
Prior art keywords
itsapplication
antiparasitic
closantel
medicamentous form
medicamentous
Prior art date
Application number
BG101703A
Other languages
Bulgarian (bg)
Other versions
BG63072B1 (en
Inventor
Марин ДРУМЕВ
Драго Друмев
Божидар ПЕТКОВ
Яна Мизинска-Боевска
Любомила Горчилова
Борис Георгиев
Катя РАДЕВА
Мария Тодорова
Мариана Караниколова
Стела Веселинова
Original Assignee
"Биовет" Ад
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Биовет" Ад filed Critical "Биовет" Ад
Priority to BG101703A priority Critical patent/BG63072B1/en
Publication of BG101703A publication Critical patent/BG101703A/en
Publication of BG63072B1 publication Critical patent/BG63072B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The form is used in the veterinary medicine practice in thecontrol of helminthosis - nematodiasis and trematodosis inruminants. It contains the usual auxiliary substances andcombination of avermectine and closantel and its soluble salts.The ratio between the avermectines and closantel is from 1:12 to1:80. The combination of active ingredients is the above ratioshows synergism.
BG101703A 1997-06-30 1997-06-30 Antiparasitic medicamentous form and method for its application BG63072B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BG101703A BG63072B1 (en) 1997-06-30 1997-06-30 Antiparasitic medicamentous form and method for its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG101703A BG63072B1 (en) 1997-06-30 1997-06-30 Antiparasitic medicamentous form and method for its application

Publications (2)

Publication Number Publication Date
BG101703A true BG101703A (en) 1997-12-30
BG63072B1 BG63072B1 (en) 2001-03-30

Family

ID=3927149

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101703A BG63072B1 (en) 1997-06-30 1997-06-30 Antiparasitic medicamentous form and method for its application

Country Status (1)

Country Link
BG (1) BG63072B1 (en)

Also Published As

Publication number Publication date
BG63072B1 (en) 2001-03-30

Similar Documents

Publication Publication Date Title
GR1003011B (en) Novel formulation
PL317105A1 (en) Compositions containing dna and p53 damaging agents
NZ333380A (en) 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof
TW347339B (en) Oral delivery of discrete units
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
HU9503085D0 (en) Veterinary composition containing a proton pump inhibitor
EP1275396A3 (en) Use of angiotensin II fragments and analogs thereof in tissue repair
ZA947338B (en) Use of angiotensin II and analogs thereof in tissue repair
MY125556A (en) Aqueous formulations of peptide
DE69412120D1 (en) IMPLANT CONSTRUCTION
MX9702170A (en) Use of aromatase inhibitors in the preparation of a drug for treating a relative androgen deficiency in men.
MX9704037A (en) 2-substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
BG102696A (en) Antipsoriasic nail varnish
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
ES8707488A1 (en) Biologically active ketone derivative, preparation and use.
DK0871467T3 (en) New formulation for delivery of peptide
BG103262A (en) Antimycotic gel with high degree of active substance release
ZA935086B (en) Skin regenerating cosmetic composition
DE69924483D1 (en) COMBINATION THERAPY FOR THE TREATMENT OF TUMORS
BG101703A (en) Antiparasitic medicamentous form and method for itsapplication
PT83322A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERTENSION OF BLOOD CONTAINING AN INHIBITOR OF THE ANGIOTENSIN CONVERSATION ENZYME IN SYNERGIC MIX WITH A DIURETIC DRAG AGENT
NZ333443A (en) Method of treating a plant disease comprising applying oxi-fulvic acid an acitve ingredient
EP0260400A3 (en) Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)-ethyl]anthranilonitrile
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
MX9701531A (en) Combination therapy to treat osteoporosis-polyphosphonates or progestins and estrogen agonists.